InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 235617

Saturday, 10/28/2017 5:07:03 PM

Saturday, October 28, 2017 5:07:03 PM

Post# of 346132
Infinity Pharmaceuticals - IPI-549 - Dr Jedd Wolchok - Rahul ex Peregrine analyst - effector function...

Now this was interesting, Infinity completed reverse merger with Discover Partners International
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=27639

Meanwhile, the company is working to identify its first candidates for clinical testing, the first of which could be rolled out in the next two to three years, Johnson said.
Several other former Ventana executives, including recently named Chief Business Officer John Lubniewski, are leading the effort. HTG founder and former CEO Bruce Seligmann is now chief science officer, directing much of the new-product research.
..
..
High Throughput Genomics Inc. was founded in 1997 as a subsidiary of SIDDCO (Systems Integration Drug Discovery Co.), which was started by biochemist Bruce Seligmann. HTG was spun off in 2001 when SIDDCO was acquired by San Diego-based Discovery Partners International Inc.

https://www.htgmolecular.com/company/media/news/68



.....lots of libraries of chemical compounds being built....Biomarkers are still KEY and Ronin hedge group must know this as Joel McComb ties to Bruce Seligmann...

I want a third party to join this race.....which I expect higher highs and higher lows ....wonder what Dr Jedd Wolchok has for everyone in Nov
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News